Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/13/2021
Arbutus Biopharma in Licensing Deal With Qilu Pharma in China
12/13/2021
Fosun's Wangbang Discountinues Development of Sirona'sr SGLT2 Inhibito...
12/13/2021
Chinese Couple Arrested in the U.S. for Scheme to Smuggle mRNA Cancer ...
12/13/2021
Biosion Licenses Worldwide Rights of Anti-TROP-2 mAb BSI04702 to OBI P...
12/13/2021
Clover and Ascentage in Clinical Collaboration to Evaluate SCB-313 in...
12/13/2021
CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...
12/13/2021
China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...
12/13/2021
Billionaire's Bet on Pfizer Vaccine for China Fails to Pay Off (Bloomb...
12/13/2021
Nine Observations from A Busy Few Weeks Back at the Heart of the China...
12/10/2021
Recent Executive Moves
12/9/2021
Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to...
12/9/2021
CANbridge Pharma Launches IPO on the Main Board of Hong Kong Stock Ex...
12/9/2021
Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...
12/9/2021
China Extends Crackdown of BMI Frauds for Another Year
12/8/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (49th ...
12/8/2021
CDE Issues the Technical Guidelines for Clinical Trials of Weight Cont...
12/8/2021
CDE Issues Three Preclinical Guidance Documents for Covid-19 Drugs
12/8/2021
CDE Issues the Technical Guidelines for Application of Biomarkers in C...
12/8/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Evaluat...
12/8/2021
CDE Solicits Comments on the Technical Guidelines for Endpoints in Adv...
12/8/2021
Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...
12/8/2021
China Approves Brii Biosciences' COVID-19 Treatment
12/8/2021
Three Chinese Biopharma Firms to Start Producing Russian Covid-19 Vacc...
12/7/2021
Sanofi Scores A Trademark Win in China
12/6/2021
Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...
12/6/2021
Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...
12/6/2021
Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...
12/6/2021
SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...
12/6/2021
Fujifilm Irvine Scientific Establishes Innovation Center in China
12/6/2021
Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...
Page:
157
/
774
Total number of articles:
23207
:
[First]
[<<]
[155]
[156]
[157]
[158]
[159]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit